[PDF] tandfonline.com

A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients

A Dakin, R Borrow, PD Arkwright - Expert Review of Vaccines, 2023 - Taylor & Francis
Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination
in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis …
被引用次数：6 相关文章 所有 5 个版本

A randomized, controlled study of DTaP-IPV-HB-PRP-T, a fully liquid hexavalent vaccine, administered in a 3-, 5-and 11-to 12-month schedule

T Vesikari, SA Silfverdal, E Jordanov… - The Pediatric Infectious …, 2017 - journals.lww.com
Background: To assess the immunogenicity and safety of a fully liquid, ready-to-use
hexavalent DTaP-IPV-HB-PRP-T vaccine when administered in a 2+ 1 schedule at 3, 5 and …
被引用次数：30 相关文章 所有 7 个版本

DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age

P Obando-Pacheco, I Rivero-Calle… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Combination vaccines reduce the number of injections received by children,
hence improving timeliness and coverage, and general acceptability among caregivers and …
被引用次数：10 相关文章 所有 3 个版本

Review of a new fully liquid, hexavalent vaccine: Hexaxim

MC Nunes, SA Madhi - Expert Opinion on Biological Therapy, 2013 - Taylor & Francis
Introduction: The introduction of injectable vaccines targeting new diseases into childhood
immunization programs has resulted in the need for combination vaccines to reduce the …
被引用次数：22 相关文章 所有 3 个版本
[PDF] academia.edu

A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children

AGB Aquino, MG Brito, CEA Doniz, JFG Herrera… - Vaccine, 2012 - Elsevier
OBJECTIVES: To evaluate an investigational, fully liquid hexavalent diphtheria-tetanus-
acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae type b (DTaP …
被引用次数：40 相关文章 所有 12 个版本
[HTML] springer.com

[HTML][HTML] DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination

YY Syed - Pediatric Drugs, 2019 - Springer
Hexyon® is a fully-liquid, ready-to-use, hexavalent vaccine approved in the EU since 2013
for primary and booster vaccination in infants and toddlers from age 6 weeks against …
被引用次数：33 相关文章 所有 6 个版本

A phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at two, three, four and twelve months

T Vesikari, T Becker, AF Vertruyen… - The Pediatric …, 2017 - journals.lww.com
Background: Combination vaccines simplify vaccination visits and improve coverage and
timeliness. Diphtheria–tetanus toxoids–acellular pertussis 5, hepatitis B, inactivated …
被引用次数：31 相关文章 所有 5 个版本

A randomized controlled study of a fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccinations of healthy infants and toddlers in Latin …

P López, AA Mohs, AA Vásquez… - The Pediatric …, 2017 - journals.lww.com
Background: Hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-
hepatitis B-Haemophilus influenzae type b (DTaP-IPV-HB-PRP-T)–containing vaccines are …
被引用次数：33 相关文章 所有 4 个版本

DTaP-IPV-Hep B-Hib Vaccine (Hexaxim®) A Review of its Use in Primary and Booster Vaccination

PL McCormack - Pediatric Drugs, 2013 - Springer
Abstract Hexaxim®(DTaP-IPV-Hep B-Hib) is a new, thiomersal-free, fully liquid, hexavalent
combination pediatric vaccine containing diphtheria and tetanus toxoids, acellular pertussis …
被引用次数：41 相关文章 所有 6 个版本

A phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11–12 months

SA Silfverdal, G Icardi, T Vesikari, SA Flores… - Vaccine, 2016 - Elsevier
Background Combination vaccines simplify vaccination visits and improve coverage and
timeliness. DTaP5-HB-IPV-Hib is a new investigational, fully-liquid, combination vaccine …
被引用次数：43 相关文章 所有 10 个版本